SEP 11, 2019 10:52 AM PDT

Insulin Drug Could Treat Glioblastoma

WRITTEN BY: Nouran Amin

A molecule used for drug delivery of insulin was recently found by researchers at the University of Georgia’s Regenerative Bioscience Center to hold treatment capabilities for an aggressive and fatal form of brain cancer—glioblastoma.

Glioblastoma is a fast-growing tumor that arises from supportive tissue around the brain that eventually resist any surgical treatment. The tumor cells become challenging to remove when it is surrounded by healthy brain tissue. More than half of all new cases pass away within the first 15 months. However, the death of late U.S. Sens. John McCain and Ted Kennedy have brought national awareness to that particular cancer and more research attention.

Learn more about glioblastoma:

Now, researchers at the University of Georgia (UGA), discovered that ‘surfen’--a compound first introduced in 1938—is a pharmaceutical agent for optimizing insulin delivery. The researchers described that surfen-treated cells did not further the tumor growth or the the spread of tumor cells.

The MRI image shows the effects of the surfen treatment] pretty drastically.The non-treated image indicates see rampant invasive growth in comparison to the surfen-models where you see a contained tumor.”

Image Credit UGA.edu

“This study shows that we can stifle the growth of invasive brain tumors with a compound that has a substantial clinical advantage, and can aid in the reduction or refinement of mainstream treatments, particularly radiation and/or chemo,” said Lohitash Karumbaiah, associate professor of regenerative medicine in UGA’s College of Agricultural and Environmental Sciences.

Findings of the study were reported in the FASEB Journal. It was the first to report the use of surfen as an application for the treatment of glioblastoma.

“In basic terms, surfen is highly positively charged and will bind to negatively charged things,” said Meghan Logun, a graduate student working with Karumbaiah. “Since we study sugars in the brain, which are highly negatively charged, we then asked, ‘Why not try using positive charges to block off the negative ones? In the surfen-treated animals, we saw that the tumors were actually much more constrained and had more defined boundaries.”

From UGA.edu: Lohitash Karumbaiah at work in his lab. (Photo by Dorothy Kozlowski/UGA)

“The tumor may still grow, but at least now it doesn’t have any invasive inroads to creep into other parts of the brain,” said Karumbaiah. “That could be clinically beneficial for a surgeon wanting to remove the tumor and not having to worry about rogue cancer cells. Our hope is that, in the wake of this discovery, lives can be saved, and we can finally change the scope of this life-threatening disease.”

Source: Science Daily

 

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
NOV 29, 2021
Genetics & Genomics
A CRISPR-Based Technique to Make New Antibiotics
NOV 29, 2021
A CRISPR-Based Technique to Make New Antibiotics
There are many bacterial organisms, and they can live cooperatively, or they can battle one another. They are also capab ...
DEC 06, 2021
Microbiology
Sino Biological Launched Omicron Variant Research Reagents
DEC 06, 2021
Sino Biological Launched Omicron Variant Research Reagents
Sino Biological Newly Launched A Panel of Research Reagents for SARS-CoV-2 Omicron Variant (B.1.1.529) Beijing, China, D ...
DEC 11, 2021
Health & Medicine
Third Dose of Pfizer-BioNTech Vaccine Could Reduce Effects of Omicron
DEC 11, 2021
Third Dose of Pfizer-BioNTech Vaccine Could Reduce Effects of Omicron
Many mainstream media sources are reporting on a new press release from Pfizer that suggests that a third dose of the Pf ...
DEC 17, 2021
Cannabis Sciences
Δ9-THCP: The Novel Phytocannabinoid with Higher Cannabimimetic Activity than THC
DEC 17, 2021
Δ9-THCP: The Novel Phytocannabinoid with Higher Cannabimimetic Activity than THC
Two novel phytocannabinoids from Cannabis sativa L. have been identified – one with a higher in vivo cannabimimeti ...
JAN 14, 2022
Drug Discovery & Development
Repurposing Drugs 101
JAN 14, 2022
Repurposing Drugs 101
Drug development is expensive. Taking into account costs of failed trials, the average drug costs $985 million to resear ...
JAN 21, 2022
Coronavirus
Negative side effects from the COVID-19 vaccine may be all in your head
JAN 21, 2022
Negative side effects from the COVID-19 vaccine may be all in your head
Did you suffer from a headache, fever, or body aches and chills after you received the COVID-19 vaccine? You aren’ ...
Loading Comments...